The United States Attorney for the District of Connecticut announced that a 39-year-old man was sentenced on July 29, 2025, to 16 months in federal prison, followed by two years of supervised release, for tampering with and stealing Lorazepam vials from the hospital where he was employed as a registered nurse.
According to court documents and statements made in court, the defendant had access to secure hospital locations used to store controlled substances, including Lorazepam. On January 31, 2022, he removed vials intended for patient use, extracted a portion of the medication from at least one vial, replaced it with an inert solution, and returned the altered vial to the storage area.
Hospital staff, who were investigating possible drug tampering, confronted the defendant that same day. A search of his backpack revealed vials, crimping tools, saline, vial caps, and syringes.
On December 11, 2024, he pleaded guilty to tampering with a consumer product and obtaining a controlled substance through fraud and deception.
The defendant is currently released on a $50,000 bond and is scheduled to report to prison on October 21. His nursing license is suspended.
Compliance Perspective
Issue
Experts estimate that 17.1 percent of the US population is affected by alcohol or drug dependency. Nurses, due to their routine access to medications, may be at increased risk for developing substance use disorders. In healthcare settings, the diversion of controlled substances by staff can result in serious consequences—including harm to residents, legal and regulatory violations, and high scope and severity citations. Such diversion may constitute abuse, neglect, misappropriation, and fraud under state and federal regulations. Staff engaged in diversion often use various methods to conceal their actions. Facilities must proactively implement diversion-prevention programs that focus on identifying medications at high risk of diversion, recognizing behavioral and documentation-related signs of diversion, and detecting symptoms of staff impairment.
Discussion Points
- Regularly review and update your facility’s policies and procedures for preventing, identifying, and responding to drug diversion. Ensure alignment with current state and federal regulations, and address emerging trends and methods of diversion.
- Provide ongoing training for appropriate staff on recognizing and responding to suspected diversion. Emphasize the potential harm to residents and the classification of diversion as a form of abuse and neglect. Reinforce staff responsibility to report concerns promptly and clarify the legal and disciplinary consequences of medication theft.
- Conduct routine audits to ensure that all controlled substances are properly documented and reconciled at the end of each shift. Review medication records for discrepancies or patterns that may indicate diversion. Involve your consultant pharmacist in this process to support compliance and early detection of issues.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*